DEF 14A

Company

Forte Biosciences, Inc.

Filed

April 19, 2019

Period of Report

May 29, 2019

Accession Number

0001564590-19-012097

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →